Placeholder Banner

EU’s Anti-Science Comitology Reform Threatens Innovation

February 14, 2017

The Biotechnology Innovation Organization (BIO) issues the following statement in response: 

“BIO is extremely discouraged by the European Commission’s new proposal to alter voting procedures regarding product authorizations, such as import authorizations for GMOs.
  

“This process, known as Comitology, has been broken for years because it allows politics to undermine the risk assessment function of the European Food Safety Authority (EFSA) and other independent European risk assessment agencies. However, with this proposal the Commission is attempting to shift responsibilities back to the Member States rather than working towards building confidence and consensus in support of the independent scientific opinions of EFSA. 
 

“This proposal adds substantial uncertainty regarding the future of EU import approvals for GMO crops and the ability of Europe’s food chain to have access to a reliable and safe supply of high quality imported grains and oilseeds.  Further, this move sends yet another message that Europe has no interest in encouraging investment and innovation in agricultural technologies.”  

Discover More
BIO to Transition Agricultural and Environmental Biotech Workstreams  Key Senior Hires Bolster Focus on Regulatory Affairs, Emerging Companies   and Economic Growth   Washington, DC, May 28, 2025 – The Biotechnology Innovation…
“Most favored nation is a deeply flawed proposal that would devastate our nation’s small- and mid-size biotech companies – the very companies that are the leading drivers of medical innovation in the United States and the cornerstone of America’s…
WASHINGTON, DC, April 8, 2025 – Today, the National Security Commission on Emerging Biotechnology (NSCEB), a bipartisan legislative commission established by Congress, issued its much-anticipated report detailing how the United States risks…